Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations

Kay Wang, Jan Y. Verbakel, Jason Oke, Alexander Fleming-Nouri, Norihiro Harada, Ryo Atsuta, Tomoyuki Fujisawa, Tomotaka Kawayama, Hiromasa Inoue, Stephen Lazarus, Stanley Szefler, Fernando D. Martinez, Dominick Shaw, Ian D. Pavord, Mike Thomas

Source: Eur Respir J, 56 (2) 2002809; 10.1183/13993003.02809-2020
Journal Issue: August
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kay Wang, Jan Y. Verbakel, Jason Oke, Alexander Fleming-Nouri, Norihiro Harada, Ryo Atsuta, Tomoyuki Fujisawa, Tomotaka Kawayama, Hiromasa Inoue, Stephen Lazarus, Stanley Szefler, Fernando D. Martinez, Dominick Shaw, Ian D. Pavord, Mike Thomas. Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations. Eur Respir J, 56 (2) 2002809; 10.1183/13993003.02809-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis
Source: Eur Respir J, 55 (5) 1902150; 10.1183/13993003.02150-2019
Year: 2020



Does the measurement of exhaled nitric oxide before and after specific inhalation challenges improve the diagnosis of occupational asthma?
Source: International Congress 2019 – Occupational lung diseases: from diagnostic techniques to classical and novel causes
Year: 2019




Is exhaled nitric oxide measurement useful in clinical practice?
Source: ISSN=ISSN 1810-6838, ISBN=, page=185
Year: 2006

Clinical utility of fractional exhaled nitric oxide in severe asthma management
Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019
Year: 2020



Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review
Source: Eur Respir J 2016; 47: 751-768
Year: 2016



Treatment decisions with an exhaled nitric oxide (eNO)-based algorithm vs a symptoms-based algorithm for asthma in pregnancy
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018




Exhaled nitric oxide in childhood asthma: methodological issues and clinical applications
Source: Eur Respir Rev 2006; 15: 215-217
Year: 2006



The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance?
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010


Opinions towards the implementation of spirometry and exhaled nitric oxide testing in children under investigation for asthma in primary care
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018


Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma?
Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019
Year: 2020



Assessing asthma control: questionnaires and exhaled nitric oxide provide complementary information
Source: Eur Respir J 2008; 32: 1419-1420
Year: 2008


Predictive value of exhaled nitric oxide in the management of asthma: a systematic review
Source: Eur Respir J 2016; 48: 706-714
Year: 2016



Investigation on the effectiveness of the Mostgraph and fractional exhaled nitric oxide measurement in chronic cough
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012


Experiences of exhaled nitric oxide measurements in diagnostics of occupational asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 281s
Year: 2001

An eye to the future: exhaled nitric oxide as a predictor of clinical outcomes in asthma
Source: Eur Respir J 2010; 35: 1200-1202
Year: 2010


Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019
Year: 2019



Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Technical problems with measurements of biomarkers - exhaled nitric oxide
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017